PMID: 9133704Apr 1, 1997Paper

Selection of the optimal scanning agent for thyroid cancer

Thyroid : Official Journal of the American Thyroid Association
J C Sisson

Abstract

Physical and biologic principles, availability, and experience in use determine which radiopharmaceuticals will be the optimal agents to portray scintigraphically thyroid cancers. However, clinical reasoning must dictate which scanning procedure to use and when. To identify functioning thyroid nodules, and thereby exclude malignancy and also disclose the source of excess thyroid hormone, technetium Tc 99m pertechnetate is the agent of choice. To evaluate patients with metastatic differentiated thyroid cancer (DTC) for possible radiopharmaceutical therapy, low doses (no more than and probably less than 74 MBq or 2 mCi) of 131I iodide are preferred. 131I is especially necessary if dosimetry is undertaken to help prescribe the optimal therapeutic dose of 131I. For less well differentiated tumors that do not concentrate 131I, most experience has been with thallium 201, which enables depiction of most metastases, but, in time, newer agents may be found to produce superior scans. The goal of imaging of the less well differentiated cancers must be to direct additional therapy such as external beam radiation of surgical excision. It is unlikely that any scanning procedure that depends on the physiologic and biochemical activities of DT...Continue Reading

References

Mar 1, 1979·The Journal of Clinical Endocrinology and Metabolism·D E HellmanR O'Mara
Oct 1, 1975·The British Journal of Surgery·K E Halnan
Mar 1, 1988·Clinical Nuclear Medicine·C A HoefnagelJ B van der Schoot
Jun 1, 1988·Clinical Nuclear Medicine·J J YobbagyT Polley
Oct 1, 1988·The Journal of Clinical Endocrinology and Metabolism·N A SamaanR C Hickey
Jan 1, 1982·European Journal of Nuclear Medicine·G SzonyiI Hales
Jul 1, 1983·The Journal of Clinical Endocrinology and Metabolism·M F SaadN A Samaan
Jul 1, 1995·Seminars in Nuclear Medicine·J O OlsenM S O'Dorisio
Jan 1, 1994·Acta Oncologica·W A CrampM Harms-Ringdahl
May 1, 1994·Clinical Nuclear Medicine·Y KrauszB Glaser
Jan 1, 1994·Thyroid : Official Journal of the American Thyroid Association·H M ParkA Manatunga
Oct 1, 1995·Thyroid : Official Journal of the American Thyroid Association·D J MarshB G Robinson
Jan 1, 1996·European Journal of Nuclear Medicine·J NĕmecR Bílek

❮ Previous
Next ❯

Citations

Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rick L M HaasHarry Bartelink
Sep 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Wellington Hung, Nicholas J Sarlis
Oct 10, 1998·Clinical Radiology·K S Naik, R F Bury
Mar 27, 2015·Health Physics·Vladimir DrozdovitchSteven L Simon
Sep 5, 2020·Journal of Nuclear Medicine Technology·Twyla B Bartel ChairShari Moreau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Thyroid : Official Journal of the American Thyroid Association
R R Cavalieri
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
H BihlF Eisenberger
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
D L Brown
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
A S Soltan, R B Hutcheson
© 2021 Meta ULC. All rights reserved